Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
02.04.1982- 31.08.1982
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: see 'Remark'
Remarks:
GLP study performed according to standard Ames testing guidelines with no major deviations (minor deviations: the test substance was tested up to very slight toxicity, no more than 27% toxicity in strain TA98 (without S9-mix) and 2-aminoanthracene alone is insufficient as a positive control with S9).

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1982
Report date:
1982

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other: Directive 79/831/EEC
Deviations:
yes
Remarks:
: 2-aminoanthracene alone is insufficient as a positive control with S9
GLP compliance:
not specified
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
4,4'-methylenebis(cyclohexylamine)
EC Number:
217-168-8
EC Name:
4,4'-methylenebis(cyclohexylamine)
Cas Number:
1761-71-3
Molecular formula:
C13H26N2
IUPAC Name:
4,4'-methylenedicyclohexanamine
Details on test material:
- Name of test material (as cited in study report): cyclohexyl,4,4'-methylenebis-
- Analytical purity: no data ("rein")

Method

Target gene:
histidine locus
Species / strain
Species / strain / cell type:
other: S.typhimurium strains TA1535, TA1537, TA1538, TA98 and TA100
Details on mammalian cell type (if applicable):
not applicable
Additional strain / cell type characteristics:
not specified
Metabolic activation:
with and without
Metabolic activation system:
Clophen A 50 induced rat liver
Test concentrations with justification for top dose:
- Dosing: 4, 12.5, 40, 125, 400 ug/plate
- Additional experiment: 125, 400, 800 ug/plate
Vehicle / solvent:
- Vehicle/solvent used: ethanol (70%)
Controlsopen allclose all
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
Remarks:
: 70% ethanol
True negative controls:
not specified
Positive controls:
yes
Positive control substance:
other: 9-aminoacridine for TA1537, sodium azide for TA100 and TA1535, 2-nitrofluorene for TA98 and TA1538
Remarks:
without S9
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
Remarks:
: 70% ethanol
True negative controls:
not specified
Positive controls:
yes
Positive control substance:
other: 2-aminoanthracene for all strains
Remarks:
with S9
Details on test system and experimental conditions:
PLATE INCORPORATION TEST
The following components were mixed in a sterile tube:
-2 mL top-agar
-0,1 mL of the bacterial overnight culture (0,8- 1,5x 10^8 bacteria/ mL)
-0,01 mL of the test item or solvent
-0,5 mL S9 mix
The mixing was done in triplicate for each bacterial strain and for each concentration of the test material and the mixture was then poured onto the surface of minimal agar plates.
-Incubation: 72 hours, 37 °C and then the number of revertant colonies was counted
Rationale for test conditions:
The toxicity of the test item was tested with and without metabolic activation. Doses from 62,5 µg - 2000 µg/ plate were tested. As the highest test dose 800 µg/ plate were chosen (survival of 10-15 % without and 70 % with metabolic activation)
Evaluation criteria:
CRITERIA FOR EVALUATING RESULTS:
- Dose related increase in the number of revertant colonies
Statistics:
not applicable

Results and discussion

Test results
Species / strain:
other: S. typhimurium strains TA1535, TA1537, TA1538, TA98 and TA100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
other: 800 ug/plate
Vehicle controls validity:
not specified
Untreated negative controls validity:
not specified
Positive controls validity:
not specified
Additional information on results:
GENOTOXIC EFFECTS:
- With metabolic activation: negative
- Without metabolic activation: negative,
TA1538 additional experiment; 3-fold increase. However, in one experiment only.

PRECIPITATION CONCENTRATION:
- no precipitate

CYTOTOXIC CONCENTRATION:
- With metabolic activation: very slight toxicity at 800 ug/plate
- Without metabolic activation: very slight toxicity at 800 ug/plate

STATISTICAL RESULTS:
- not applicable

Applicant's summary and conclusion

Conclusions:
An Ames-test was performed to assess the mutagenis properties of the test item. The test item was proven to be non mutagenic in the absence and presence of S9 mix.
Executive summary:

The test item was tested for its ability to induce reverse mutations in an in vitro bacterial system. Salmonella typhimurium strains TA 98, TA 100, TA 1535, TA 1537 and TA 1538 were treated with the test compound by the Ames test plate incorporation. Dose levels up to 800 µg/ plate, in triplicate both with and without the addition of metabolising system were employed.

All bacterial strains exhibited mutagenis responses to the appropriate positive control substances. Solvent controls were also tested with each strain and the mean numbers of spontaneous revertants were in an acceptable range. 

A reproducible mutagenic activity of the test compound to any of the tester strains was not observed with and without metabolic activation.

It is therefore concluded, that the test item is not a bacterial mutagen.